SCHEMBL10275637

SCHEMBL10275637

CCOC(=O)c1c(O)[nH]c2c(-c3ccc(F)cc3F)c(CC)nn2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.37
PTGES O14684 1/20 0.37
SLC34A1 Q06495 2/20 0.37
PLAT P00750 3/20 0.37
HPGD P15428 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 1/20 0.35
ALPL P05186 1/20 0.35
LMNA P02545 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275179 0.90 PLAT (0.40) ALOX5PTGESSLC34A1PLATHPGD
SCHEMBL10276170 0.87 PLAT (0.45) ALOX5PTGESSLC34A1PLATHPGD
SCHEMBL10275916 0.86 ARF6 (0.43) ALOX5PTGESSLC34A1PLATHPGD
SCHEMBL10275932 0.86 ALDH1A1 (0.39) ALOX5SLC34A1PLATHPGDMEN1
SCHEMBL10275405 0.85 PLAT (0.46) ALOX5PTGESSLC34A1PLATHPGD
SCHEMBL10275761 0.85 SLC34A1 (0.40) SLC34A1HPGDMEN1KMT2AALDH1A1
SCHEMBL10313571 0.80 CYP1A2 (0.39) PLATHPGDNPSR1TSHRALDH1A1
SCHEMBL10275766 0.78 MAPT (0.43) ALOX5PLATMEN1KMT2AALDH1A1
SCHEMBL10313549 0.78 MAPT (0.45) SLC34A1HPGDMEN1KMT2AALDH1A1
SCHEMBL10313537 0.77 MAPT (0.46) ALOX5PTGESSLC34A1PLATHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 ALOX5 1282/4885PTGES 2534/4885SLC34A1 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.